As more people turn to this medication, concerns about cost and accessibility have made headlines, particularly regarding its impact on Medicare
An experimental drug appears to outperform the trendy medications Wegovy and Ozempic for both weight loss and diabetes control, a pair of early clinical trials shows
Cell Metab , 2016, 24: 657671 Kruse B, Buzzai AC, Shridhar N, Braun AD, Gellert S, Knauth K, Pozniak J, Peters J, Dittmann P, Mengoni M, van der Sluis TC, Hhn S, Antoranz A, Krone A, Fu Y, Yu D, Essand M, Geffers R, Mougiakakos D, Kahlfu S, Kashkar H, Gaffal E, Bosisio FM, Bechter O, Rambow F, Marine JC, Kastenmller W, Mller AJ, Tting T
Dans les formes graves, peut exister une insuffisance pancratique squellaire, soit de type endocrine (diabte sucr), soit de type exocrine, ncessitant la prescription d'extraits pancratiques